March 16, 2010 - SenoRx Inc. released a statement yesterday announcing with great sadness of its chairman and chief executive officer (CEO), Lloyd H. Malchow.
Mr. Malchow passed away Sunday evening, March 14. The company extends its deepest condolences to his family. It had been announced on February 8 that Mr. Malchow was taking an indefinite medical leave of absence to undergo medical treatment for cancer. Mr. Malchow is survived by his wife and two daughters.
"Lloyd was an exceptional leader, business colleague and friend," said John Buhler, SenoRx president, chief operating officer and acting CEO. "He leaves a legacy of excellence and accomplishment as a business leader. His SenoRx family will miss him tremendously. He will always be remembered for his passion and commitment to both his work and his family. Through his compassion and tenacity he inspired all of us to be our best."
SenoRx develops, manufactures and sells minimally invasive medical devices used by breast care specialists for the diagnosis and treatment of breast cancer, including its EnCor vacuum-assisted breast biopsy system and Contura MLB catheter for delivering radiation to the tissue surrounding the lumpectomy cavity following surgery for breast cancer. SenoRx's field sales organization serves over 2,000 breast diagnostic and treatment centers in the United States.
For more information:
www.senorx.com
February 18, 2026 
